Work

GLP-1 receptor agonist therapy and cancer risk and mortality in patients with moderate CKD: A national matched cohort study of 58,000 patients.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.10583

Authors: Muneeb Asad, Almir Durmishi, Dina Abed, Omar Diab, Muhammad Bilal Abid

Institutions: Texas Tech University Health Sciences Center, Texas Tech University, The University of Texas Medical Branch at Galveston

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162519343

Cites:

Cited by: 1

Related to: